Log in to save to my catalogue

European Society of Breast Imaging (EUSOBI) guidelines on the management of axillary lymphadenopathy...

European Society of Breast Imaging (EUSOBI) guidelines on the management of axillary lymphadenopathy...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6e3ce0c729974b2ca4517aaf9d8abd8e

European Society of Breast Imaging (EUSOBI) guidelines on the management of axillary lymphadenopathy after COVID-19 vaccination: 2023 revision

About this item

Full title

European Society of Breast Imaging (EUSOBI) guidelines on the management of axillary lymphadenopathy after COVID-19 vaccination: 2023 revision

Publisher

Vienna: Springer Vienna

Journal title

Insights into imaging, 2023-07, Vol.14 (1), p.126-126, Article 126

Language

English

Formats

Publication information

Publisher

Vienna: Springer Vienna

More information

Scope and Contents

Contents

Axillary lymphadenopathy is a common side effect of COVID-19 vaccination, leading to increased imaging-detected asymptomatic and symptomatic unilateral axillary lymphadenopathy. This has threatened to negatively impact the workflow of breast imaging services, leading to the release of ten recommendations by the European Society of Breast Imaging (E...

Alternative Titles

Full title

European Society of Breast Imaging (EUSOBI) guidelines on the management of axillary lymphadenopathy after COVID-19 vaccination: 2023 revision

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_6e3ce0c729974b2ca4517aaf9d8abd8e

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6e3ce0c729974b2ca4517aaf9d8abd8e

Other Identifiers

ISSN

1869-4101

E-ISSN

1869-4101

DOI

10.1186/s13244-023-01453-2

How to access this item

Log in as a Library member